drugset / Trial / NCT00430040
Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine whether addition of Carvedilol CR to diabetic patients with hypertension who are receiving the ACEi,Lisinopril,will provide added benefits to blood vessels when compared to treatment with Lisinopril alone.It is believed that carvedilol provides added benefits by suppressing free radicals(charged substances that cause damage to the body ) and inflammation.
Timeline
- Start
- 2007-02
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 80 mg | Oral |
| Subject | LISINOPRIL ANHYDROUS | Small molecule | 20 mg | — |